Orthopaedic knee implant makers push for self-regulation of prices

In India, 120,000 knee implant procedures are conducted every year

National Pharmaceutical Pricing Authority’s (NPPA) focus on orthopaedic knee implants has made the industry jittery. The multinational corporation like Johnson and Johnson, Zimmer Biomet, Smith and Nephew, Vygon that manufacture these implants are willing to work towards self-regulating prices instead of letting the government do it. Last time, the National Pharmaceutical Pricing Authority (NPPA) stepped in was to bring down prices of cardiac stents. The way in which the NPPA priced stents shook the entire industry. 

The Medical Technology Association of India (MTAI) met has proposed to form a proposal for making medical devices more affordable. Sushobhan Dasgupta, managing director,